Robert Croese
YOU?
Author Swipe
View article: Perfusion MRI-based differentiation between early tumor progression and pseudoprogression in glioblastoma and its use in clinical practice
Perfusion MRI-based differentiation between early tumor progression and pseudoprogression in glioblastoma and its use in clinical practice Open
Background Early treatment effects in patients with glioblastoma are frequently discussed during multidisciplinary team meetings (MDTM), after which a decision regarding (dis)continuation of tumor-targeted treatment is made. This study exa…
View article: Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging Open
Arterial spin labeling (ASL) and dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI) have shown potential for differentiating tumor progression from pseudoprogression. For pseudocontinuous ASL with a single postlabeling …
View article: P15.08.A MRI PHENOTYPES OF GLIOBLASTOMAS EARLY AFTER TREATMENT ARE SUGGESTIVE OF OVERALL PATIENT SURVIVAL
P15.08.A MRI PHENOTYPES OF GLIOBLASTOMAS EARLY AFTER TREATMENT ARE SUGGESTIVE OF OVERALL PATIENT SURVIVAL Open
BACKGROUND Distinguishing between true tumor progression (TP) and treatment induced abnormalities (e.g. pseudo-progression (PP) after radiotherapy) early after treatment on conventional MRI scans remains challenging for glioblastomas (GBM)…
View article: P11.07.A PERFUSION-MRI BASED DIFFERENTIATION BETWEEN EARLY TUMOR PROGRESSION AND PSEUDOPROGRESSION IN GLIOBLASTOMA AND ITS USE IN CLINICAL PRACTICE
P11.07.A PERFUSION-MRI BASED DIFFERENTIATION BETWEEN EARLY TUMOR PROGRESSION AND PSEUDOPROGRESSION IN GLIOBLASTOMA AND ITS USE IN CLINICAL PRACTICE Open
BACKGROUND Post-gadolinium MRI is considered the mainstay of radiological monitoring of treatment effects in patients with a glioblastoma. However, the radiotherapy(RT)-induced abnormality, pseudoprogression, is difficult to distinguish fr…
View article: MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival
MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival Open
Background Distinguishing true tumor progression (TP) from treatment-induced abnormalities (eg, pseudo-progression (PP) after radiotherapy) on conventional MRI scans remains challenging in patients with a glioblastoma. We aimed to establis…
View article: P15.06.B Influence of arterial transit time delays on the differentiation between tumor progression and pseudo-progression in glioblastoma by arterial spin labeling MRI
P15.06.B Influence of arterial transit time delays on the differentiation between tumor progression and pseudo-progression in glioblastoma by arterial spin labeling MRI Open
Background Perfusion MRI by Arterial Spin Labeling (ASL) and Dynamic Susceptibility Contrast (DSC) has shown its potential for differentiating tumor progression from pseudo-progression in glioblastoma patients. The ASL scans can be affecte…